Opioid Agents and Cardiac Arrhythmia: A Literature Review.
arrhythmogenicity
atrial arrhythmias.
cardiac arrythmia
chronic pain
opioids
qt interval
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
received:
01
03
2023
accepted:
22
04
2023
medline:
25
5
2023
pubmed:
25
5
2023
entrez:
25
5
2023
Statut:
epublish
Résumé
Opioids are compounds that cause similar effects to morphine by binding to its receptors. Opioids can be synthetic, semi-synthetic, or natural and can easily bind to the receptors of opioids in order to depict their effects, which may vary depending upon the exposure of the drug and its dose. However, several side effects of opioids can also be observed, with the most crucial being their impact on the heart's electrical activity. This review majorly focuses on opioids' impact on the prolongation of the QT curve and their arrhythmogenic susceptibility. Articles published up to the year 2022 in various databases were identified and searched with the use of keywords. Search terms included "cardiac arrhythmias," "QT interval," "opioids," "opioid dependence," and "torsade de pointes (TdP)". These terms highlight the impact of each opioid agent on the activity of the heart on an electrocardiogram. The results of the available data depict that opioids, such as methadone, pose higher risks, even when taken in smaller amounts, and have the capability for QT interval prolongation and TdP development. A variety of opioids, i.e., oxycodone and tramadol, are considered as intermediary risk drugs and can build long QT intervals and TdP in large doses. Several other opioids are considered low-risk drugs, including buprenorphine and morphine, which lead to no production of TdP and QT interval prolongation in daily routine doses. Evidence indicates a high risk of sinus bradycardia, atrial fibrillation, cardiac block, and supra-ventricular arrhythmias in opium consumers. This literature review will play a key role in determining the association between the use of opioids and cardiac arrhythmias. It will further highlight the practical implications of opioids for the management of cardiac issues based on their dose, frequency, and intensity. Moreover, it will also depict the adverse effects of opioids along with their dose-specific relationship. Opioids display disparate cardiac arrhythmogenicity, and methadone contains a greater ability to induce long QT intervals and hazardous arrhythmias at conventional doses. In order to reduce arrhythmogenic risk, opioids taken in large amounts should be monitored with a regular electrocardiogram in high-risk consumers, i.e., patients on opioid maintenance.
Identifiants
pubmed: 37228540
doi: 10.7759/cureus.38007
pmc: PMC10207988
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e38007Informations de copyright
Copyright © 2023, Golibkhon et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Pain Physician. 2013 Mar-Apr;16(2):E85-94
pubmed: 23511694
Expert Opin Drug Metab Toxicol. 2019 Jul;15(7):565-575
pubmed: 31211608
Ann Intern Med. 2018 Aug 7;169(3):137-145
pubmed: 29913516
Am J Public Health. 2019 Feb;109(2):215-217
pubmed: 30649947
Nursing. 2019 Apr;49(4):47-49
pubmed: 30893204
Int J Cardiol. 2016 Jun 1;212:360-3
pubmed: 27060723
Curr Pharm Des. 2014;20(36):5794-8
pubmed: 24502567
Circ Res. 2017 Jun 9;120(12):1969-1993
pubmed: 28596175
J Gen Intern Med. 2016 May;31(5):478-85
pubmed: 26553336
Br J Anaesth. 2011 Jul;107(1):8-18
pubmed: 21613279
Anesth Analg. 2017 Nov;125(5):1769-1778
pubmed: 29049121
Pain Physician. 2011 Jul-Aug;14(4):E343-60
pubmed: 21785485
Nat Rev Dis Primers. 2020 Jul 16;6(1):58
pubmed: 32678103
Circulation. 2021 Sep 28;144(13):e218-e232
pubmed: 34407637
J Arrhythm. 2016 Apr;32(2):75-81
pubmed: 27092186
Br J Pain. 2012 Feb;6(1):11-6
pubmed: 26516461
J Intern Med. 2013 May;273(5):511-26
pubmed: 23331508
J Am Heart Assoc. 2019 Feb 5;8(3):e010664
pubmed: 30689500
Adv Ther. 2014 Jul;31(7):708-23
pubmed: 25033926
Curr Cardiol Rev. 2016;12(1):27-36
pubmed: 26818485
Curr Neuropharmacol. 2017 Apr;15(3):444-456
pubmed: 28503117
Heart. 2021 Jun;107(11):909-915
pubmed: 33122299
Eur J Pain. 2010 Nov;14(10):1014-20
pubmed: 20494598
Postgrad Med. 2019 Apr;131(3):185-198
pubmed: 30700198
J Clin Sleep Med. 2014 Aug 15;10(8):847-52
pubmed: 25126029
N Engl J Med. 2021 Jan 28;384(4):305-315
pubmed: 33197159
J Pain. 2015 Sep;16(9):844-51
pubmed: 26080041
Circulation. 2021 Apr 20;143(16):e836-e870
pubmed: 33682423
Curr Pain Headache Rep. 2018 Feb 23;22(3):16
pubmed: 29476358
JAMA Cardiol. 2020 Aug 1;5(8):889-896
pubmed: 32584934
Drug Alcohol Depend. 2013 Apr 1;129(1-2):88-93
pubmed: 23084592
Annu Rev Med. 2018 Jan 29;69:451-465
pubmed: 29029586
J Clin Pharm Ther. 2020 Oct;45(5):892-903
pubmed: 31986228
J Cardiovasc Pharmacol. 2021 Feb 1;77(2):123-129
pubmed: 33235028
J Public Health (Oxf). 2018 Jun 1;40(2):409-414
pubmed: 28591852
ESC Heart Fail. 2022 Dec;9(6):3973-3984
pubmed: 35985663
Mayo Clin Proc. 2015 Jul;90(7):957-68
pubmed: 26141334
J Am Board Fam Med. 2011 Nov-Dec;24(6):717-27
pubmed: 22086815
J Gen Intern Med. 2011 Sep;26(9):965-71
pubmed: 21562923
Circ Arrhythm Electrophysiol. 2015 Jun;8(3):748-50
pubmed: 26082532
Curr Rev Clin Exp Pharmacol. 2021;16(4):330-340
pubmed: 33511945
Resuscitation. 2017 Dec;121:84-89
pubmed: 29037885
Ann Intern Med. 2015 Feb 17;162(4):276-86
pubmed: 25581257
Health Psychol Res. 2022 Oct 7;10(4):38672
pubmed: 36628122
Neurology. 2014 Sep 30;83(14):1277-84
pubmed: 25267983
Int J Cardiol. 2019 Jul 1;286:73-75
pubmed: 30674434
J Gen Intern Med. 2010 Apr;25(4):310-5
pubmed: 20049546